<DOC>
	<DOCNO>NCT01941277</DOCNO>
	<brief_summary>The purpose study evaluate effect exercise Insulin Resistance ( IR ) subject routinely exercise risk develop diabetes ( prediabetes ) . It estimate approximately 30-90 people participate study three study site United States United Kingdom .</brief_summary>
	<brief_title>Effect Exercise Insulin Resistance</brief_title>
	<detailed_description />
	<mesh_term>Insulin Resistance</mesh_term>
	<mesh_term>Prediabetic State</mesh_term>
	<criteria>Inclusion Criteria 1 . Aged 18 75 year . 2 . Meets one three diagnostic criterion list ( base screening result record result within one week enrollment ) ; 1 . Fasting plasma whole blood glucose ( fast define caloric intake least 8 hour ) : 100 ≤ 125 mg/dL ( 6.06.9 mmol/L ) 2 . HbA1c 5.7 % 6.4 % ( 39 46 mmol/mol ) 3 . 2hour plasma glucose 140199 mg/dL ( 7.811.0 mmol/L ) OGTT ( describe WHO use glucose load 75 g anhydrous glucose dissolve water ) 3 . No clinically significant adverse exercise response maximal grade exercise test Exclusion Criteria 1 . Weight loss diet program weight change ( &gt; 10 % ) within past 6 month 2 . Daily physical activity &gt; 10,000 step per day ( measure interval visit 1 2 ) 3 . Participates deliberate structure exercise 4 . Pregnant intend become pregnant 5 . Cognitive intellectual disability prevents subject provide informed consent follow protocol instruction . 6 . Unwillingness participate study procedures 7 . Inability give blood multiple venous phlebotomy intravenous catheter 8 . BMI great 40 kg/m2 9 . Concurrent participation another lifestyle modification trial 10 . Diagnosis diabetes base one follow criterion : 1 . Fasting plasma whole blood glucose ≥ 126 mg/dL ( 7 mmol/L ) 2 . HbA1c &gt; 6.5 % ( &gt; 47 mmol/mol ) 3 . 2hour plasma glucose ≥ 200 mg/dL ( 11.1 mmol/L ) OGTT 11 . Any preexist newly discover medical condition deem likely put subject risk injury trial . This may include limited : 1 . Clinically relevant vascular cerebrovascular event ( e.g . stroke , recurrent transient ischemic attack ( TIA ) , deep venous thrombosis intracardiac thrombus , clinically significant edema within previous 6 month 2 . Current use antipsychotic , anticonvulsant , anticoagulant , sedative medication , cognitionenhancing medication 3 . Current use beta blocker ( betaadrenergic block agent ) 4 . Current previous use ( within past year ) follow medication : diabetes related medication insulin ; metformin ; growth hormone ; glucagon ; dipeptidyl peptidase4 ( DPP4 ) inhibitor ( saxagliptin , stigagliptin ) ; glucagonLike Peptide1 ( GLP1 ) mimetics ( exenatide , liraglutide ) ; sulfonylurea medication potential confound medication 5 . Medical conditon predetermines insulin resistance ( e.g . Marfan syndrome / severe Polycystic ovary syndrome ( PCOS ) / Cushing syndrome etc. ) . 6 . Fasting triglyceride &gt; 1000 mg/dL .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>